We are thrilled to announce the launch of the AccelBio Open Call, a competition aimed at accelerating biomedical innovation in Portugal. Our primary mission is to facilitate the successful transfer of scientific knowledge to the economy by fostering the development of products and businesses in drug discovery.

Objective: The AccelBio Open Call seeks to identify and support projects with the most promising prospects of transitioning from research into clinical product candidates. Our ultimate goal is to capitalize on the best Portuguese discoveries and transform them into innovative drug assets.

Focus Areas: We invite proposals from Portuguese public or non-profit legal entities, including universities, research centers, and hospitals. Eligible projects should have potential as pharmaceutical therapies, particularly in the following therapeutic areas:

  • Oncology
  • Neurosciences
  • Infectious diseases
  • Immunology
  • Metabolism
  • Cardiovascular

Support Offered: Selected projects will receive a financial award of up to 50,000€ to cover services and consumables. Additionally, we will provide assistance in preparing a comprehensive value creation plan. This plan, developed with the support of the AccelBio team, will have a duration of 18 months and will encompass a series of experiments necessary to drive a drug discovery project effectively to the pre-clinical candidate stage.

How to Apply: Interested parties are invited to submit proposals outlining their research activity and its potential to be developed into assets with clinical therapeutic potential.

Submission Deadline (Extended): The deadline for proposal submission is April 14th, 2024

Join Us in Transforming Scientific Ideas into Clinical Solutions: We believe that collaboration and innovation are key drivers of progress in biomedical research. By participating in the CoLAB AccelBio Open Call, you will have the opportunity to contribute to the advancement of healthcare and make a meaningful impact on patients' lives.

For more information and to submit your proposal, please check the Guidelines and the Application Template.

Let's accelerate biomedical innovation together!

Subscribe
Sign up with your email address to receive news and updates.
Subscription Form

By subscribing to receive news and updates you are automatically agreeing with our Terms & Conditions and Privacy Policy.
Latest news

TransBioNet: Nearly €2 Million Horizon Europe Project to Bring Biomedical Research Closer to Investment Readiness

TransBioNet, a new initiative funded by the European Union’s Horizon Europe programme, has been launched to help promising biomedical research […]
Read more

Leading from Within: AccelBio Team Completes a Leadership Workshop

From October 12th to 14th, 2026, the AccelBio team stepped away from the lab and the office for a three-day […]
Read more

Knowledge Valorisation in Action: AccelBio at the REA Workshop in Brussels

AccelBio’s CEO, Bárbara Gomes, attended the workshop “Knowledge Valorisation in Action: from Results to Policy” on October 8th, 2026, at […]
Read more
1 2 3 … 18
Posted on
March 2, 2024
Author
Co-Lab AccelBio

Contact Us

geral@accelbio.pt+351 918 439 722
Call to national mobile network
Laboratório Colaborativo AccelBio
Biocant Park,
Parque Tecnológico de Cantanhede,
3060-197 Cantanhede
2026 Co-Lab AccelBio All rights reserved ©
|
Designed and built by BOTODACRUZ